GeneDx announced that Devin K. Schaffer has been appointed General Counsel, effective April 24, 2023. As a member of the executive leadership team, Devin will report directly to Katherine Stueland, President and CEO, and will be responsible for all legal, compliance, and regulatory activities for GeneDx. Devin has 15 years of legal experience and has held multiple leadership positions including his most recent role as Vice President and Associate General Counsel at Cardinal Health, a global integrated healthcare services and products company.

In this role, he successfully led the company's legal department responsible for corporate governance, securities, mergers and acquisitions, treasury, risk management, shareholder engagement, labor and employment, and bankruptcy. He also served as an advisor for Cardinal Health's Human Resources/Compensation and Governance and Sustainability Committees and advised the Executive Committee and Board of Directors on strategic transactions. Before joining Cardinal Health, Devin held previous roles as a Private Equity Associate at Jones Day and an Associate at Ice Miller, LLP.

Devin received his bachelor's degree from Indiana University and later his master's degree in business administration from Indiana University, Kelley School of Business. Devin also received his J.D. from Indiana University, where he was Managing Editor of the Indiana Law Journal. Devin is an Advisory Board Member for the John L. Weinberg Center for Corporate Governance established at the University of Delaware in 2000.

It is one of the longest-standing corporate governance centers in academia and the first and only corporate governance center in the State of Delaware, the legal home for a majority of the nation's public corporations.